Literature DB >> 19731550

Foxa1 and Foxa2 transcription factors regulate differentiation of midbrain dopaminergic neurons.

Siew-Lan Ang1.   

Abstract

Midbrain dopaminergic neurons (mDA), comprising the substanti nigra pars compacta (A8), the ventral tegmental area (A9) and the retrorubal field (A10) subgroups, are generated from floor plate progenitors, rostral to the isthmic boundary. Floor plate progenitors are specified to become mDA progenitors between embryonic days 8.0 and 10.5. Subsequently these progenitors undergo neuronal differentiation in two phases, termed early and late differentiation to generate immature and mature neurons respectively. Genes that regulate specification, early and late phases of differentiation ofmDA cells have recently been identified. Among them, the forkhead winged helix transcription factors Foxal and Foxa2 (Foxa1/2), have been shown to have essential and dose dependent roles at multiple phases of development. In this chapter, I will summarize recent studies demonstrating a role for Foxa1/2 in regulating the neuronal specification and differentiation ofmDA progenitors and conclude with projections on future directions of this area of research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19731550     DOI: 10.1007/978-1-4419-0322-8_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  20 in total

1.  Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature beta-cell.

Authors:  Nan Gao; John Le Lay; Wei Qin; Nicolai Doliba; Jonathan Schug; Alan J Fox; Olga Smirnova; Franz M Matschinsky; Klaus H Kaestner
Journal:  Mol Endocrinol       Date:  2010-06-09

Review 2.  Programming and reprogramming neuronal subtypes in the central nervous system.

Authors:  Caroline Rouaux; Salman Bhai; Paola Arlotta
Journal:  Dev Neurobiol       Date:  2012-07       Impact factor: 3.964

3.  Genome-wide characterization of Foxa2 targets reveals upregulation of floor plate genes and repression of ventrolateral genes in midbrain dopaminergic progenitors.

Authors:  Emmanouil Metzakopian; Wei Lin; Mali Salmon-Divon; Heidi Dvinge; Elisabet Andersson; Johan Ericson; Thomas Perlmann; Jeffrey A Whitsett; Paul Bertone; Siew-Lan Ang
Journal:  Development       Date:  2012-06-13       Impact factor: 6.868

4.  Selection Based on FOXA2 Expression Is Not Sufficient to Enrich for Dopamine Neurons From Human Pluripotent Stem Cells.

Authors:  Julio Cesar Aguila; Alexandra Blak; Joris van Arensbergen; Amaia Sousa; Nerea Vázquez; Ariane Aduriz; Mayela Gayosso; Maria Paz Lopez Mato; Rakel Lopez de Maturana; Eva Hedlund; Kai-Christian Sonntag; Rosario Sanchez-Pernaute
Journal:  Stem Cells Transl Med       Date:  2014-07-14       Impact factor: 6.940

Review 5.  Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.

Authors:  Jesse V Veenvliet; Marten P Smidt
Journal:  Cell Mol Life Sci       Date:  2014-07-27       Impact factor: 9.261

Review 6.  MicroRNAs and deregulated gene expression networks in neurodegeneration.

Authors:  Kai-Christian Sonntag
Journal:  Brain Res       Date:  2010-04-07       Impact factor: 3.252

Review 7.  Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.

Authors:  Lin Tan; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-06-29       Impact factor: 5.590

8.  The expression of KATP channel subunits in alpha-synuclein-transfected MES23.5 cells.

Authors:  Shuai-Shuai Han; Qian Jiao; Ming-Xia Bi; Xi-Xun Du; Hong Jiang
Journal:  Ann Transl Med       Date:  2018-05

9.  Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages.

Authors:  Simon R W Stott; Emmanouil Metzakopian; Wei Lin; Klaus H Kaestner; Rene Hen; Siew-Lan Ang
Journal:  J Neurosci       Date:  2013-05-01       Impact factor: 6.167

10.  Transcription factors FOXA1 and FOXA2 maintain dopaminergic neuronal properties and control feeding behavior in adult mice.

Authors:  Alessandro Pristerà; Wei Lin; Anna-Kristin Kaufmann; Katherine R Brimblecombe; Sarah Threlfell; Paul D Dodson; Peter J Magill; Cathy Fernandes; Stephanie J Cragg; Siew-Lan Ang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.